Curis Inc (CRIS) stock
CRISNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.45−0.13 (-22.18%)
Close on Nov 13, 2026Market cap $930.08KP/E –Yield –
Curis total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Curis's total debt was $0 at Dec 31, 2025. For fiscal 2025 it was $0, down 100.0% from the year before. The highest annual figure on record is $41.59M in fiscal 2017.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | -100.0% |
| FY2024 | Dec 31, 2024 | $7.56M | -11.1% |
| FY2023 | Dec 31, 2023 | $8.50M | – |
| FY2021 | Dec 31, 2021 | $0 | -100.0% |
| FY2020 | Dec 31, 2020 | $891.00K | – |
| FY2019 | Dec 31, 2019 | $0 | -100.0% |
| FY2018 | Dec 31, 2018 | $35.52M | -14.6% |
| FY2017 | Dec 31, 2017 | $41.59M | +109.4% |
| FY2016 | Dec 31, 2016 | $19.86M | -17.8% |
| FY2015 | Dec 31, 2015 | $24.17M | -14.6% |
| FY2014 | Dec 31, 2014 | $28.30M | -7.4% |
| FY2013 | Dec 31, 2013 | $30.56M | +2.4% |
| FY2012 | Dec 31, 2012 | $29.84M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $0 | -100.0% |
| Q3 FY2025 | Sep 30, 2025 | $6.95M | -18.3% |
| Q2 FY2025 | Jun 30, 2025 | $7.35M | – |
| Q1 FY2025 | Mar 31, 2025 | $7.23M | – |
| Q4 FY2024 | Dec 31, 2024 | $7.56M | – |
| Q4 FY2023 | Dec 31, 2023 | $8.50M | +854.4% |
| Q4 FY2021 | Dec 31, 2021 | $0 | -100.0% |
| Q3 FY2021 | Sep 30, 2021 | $0 | -100.0% |
| Q2 FY2021 | Jun 30, 2021 | $0 | -100.0% |
| Q1 FY2021 | Mar 31, 2021 | $891.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $891.00K | – |
| Q3 FY2020 | Sep 30, 2020 | $890.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $890.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | -100.0% |
| Q3 FY2019 | Sep 30, 2019 | $0 | -100.0% |
| Q2 FY2019 | Jun 30, 2019 | $0 | -100.0% |
| Q1 FY2019 | Mar 31, 2019 | $0 | -100.0% |
| Q4 FY2018 | Dec 31, 2018 | $35.52M | -14.6% |
| Q3 FY2018 | Sep 30, 2018 | $37.15M | -13.4% |
| Q2 FY2018 | Jun 30, 2018 | $38.50M | -12.3% |
| Q1 FY2018 | Mar 31, 2018 | $39.75M | -11.3% |
| Q4 FY2017 | Dec 31, 2017 | $41.59M | +109.4% |
| Q3 FY2017 | Sep 30, 2017 | $42.87M | – |
| Q2 FY2017 | Jun 30, 2017 | $43.89M | – |
| Q1 FY2017 | Mar 31, 2017 | $44.81M | – |
| Q4 FY2016 | Dec 31, 2016 | $19.86M | – |
See a number that looks wrong?